Lymphocyte cell kinase activation mediates neuroprotection during ischemic preconditioning

Journal of Neuroscience

Volumn 32, Issue 21, 2012, Pages 7278-7286

  Bae, Ok Nam ^a,b   Rajanikant, Krishnamurthy ^a   Min, Jiangyong ^a   Smith, Jeremy ^a   Baek, Seung Hoon ^a,c   Serfozo, Kelsey ^a   Hejabian, Siamak ^a   Lee, Ki Yong ^a   Kassab, Mounzer ^a   Majid, Arshad ^a,d  

^a East Lansing   (United States)

^b Hanyang University   (South Korea)

^c Ajou University   (South Korea)

^d SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; LYMPHOCYTE CELL KINASE; N METHYL DEXTRO ASPARTIC ACID; OXYGEN; PROTEIN KINASE; PROTEIN KINASE C EPSILON; PROTEIN KINASE FYN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INFARCTION; BRAIN ISCHEMIA; CELL DAMAGE; CONTROLLED STUDY; CYTOTOXICITY; GENE SILENCING; IMMUNOPRECIPITATION; ISCHEMIC PRECONDITIONING; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STROKE; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BRAIN ISCHEMIA; CELL DEATH; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; GENE SILENCING; GLUCOSE; ISCHEMIC PRECONDITIONING; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MICE; MICE, KNOCKOUT; N-METHYLASPARTATE; NEURONS; NEUROPROTECTIVE AGENTS; OXYGEN; PRIMARY CELL CULTURE; PROTEIN KINASE C-EPSILON; RNA, SMALL INTERFERING;

EID: 84861302605     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.6273-11.2012     Document Type: Article

References (61)

1. Alano CC, Garnier P, Ying W, Higashi Y, Kauppinen TM, Swanson RA (2010) NAD+ depletion is necessary and sufficient for poly(ADPribose) polymerase-1-mediated neuronal death. J Neurosci 30:2967-2978.
2. Benati D, Baldari CT (2008) SRC family kinases as potential therapeutic targets for malignancies and immunological disorders. Curr Med Chem 15:1154-1165.
3. Bright R, Sun GH, Yenari MA, Steinberg GK, Mochly-Rosen D (2008) epsilonPKC confers acute tolerance to cerebral ischemic reperfusion injury. Neurosci Lett 441:120-124.
4. Brooks G, Hearse DJ (1996) Role of protein kinase C in ischemic preconditioning: player or spectator? Circ Res 79:627-630.
5. Chen M, Lu TJ, Chen XJ, Zhou Y, Chen Q, Feng XY, Xu L, Duan WH, Xiong ZQ (2008) Differential roles of NMDA receptor subtypes in ischemic neuronal cell death and ischemic tolerance. Stroke 39:3042-3048.
6. Chen Y, Cantrell AR, Messing RO, Scheuer T, Catterall WA (2005) Specific modulation of Na+ channels in hippocampal neurons by protein kinase C epsilon. J Neurosci 25:507-513.
7. Chou WH, Messing RO (2005) Protein kinase C isozymes in stroke. [Review]. Trends Cardiovasc Med 15:47-51.
8. Dave KR, DeFazio RA, Raval AP, Torraco A, Saul I, Barrientos A, Perez-Pinzon MA (2008) Ischemic preconditioning targets the respiration of synaptic mitochondria via protein kinase C epsilon. J Neurosci 28:4172-4182.
9. DeFazio RA, Raval AP, Lin HW, Dave KR, Della-Morte D, Perez-Pinzon MA (2009) GABA synapses mediate neuroprotection after ischemic and epsilonPKC preconditioning in rat hippocampal slice cultures. J Cereb Blood Flow Metab 29:375-384.
10. Dirnagl U, Becker K, Meisel A (2009) Preconditioning and tolerance against cerebral ischemia: from experimental strategies to clinical use. Lancet Neurol 8:398-412.
11. Fagan SC (2010) Stroke: measuring disease-free life after thrombolysis. Nat Rev Neurol 6:361-362.
12. Filipp D, Zhang J, Leung BL, Shaw A, Levin SD, Veillette A, Julius M (2003) Regulation of Fyn through translocation of activated Lck into lipid rafts. J Exp Med 197:1221-1227.
13. Filipp D, Moemeni B, Ferzoco A, Kathirkamathamby K, Zhang J, Ballek O, Davidson D, Veillette A, Julius M (2008) Lck-dependent Fyn activation requires C terminus-dependent targeting of kinase-active Lck to lipid rafts. J Biol Chem 283:26409-26422.
14. Fisher M, Ratan R (2003) New perspectives on developing acute stroke therapy. Ann Neurol 53:10-20.
15. Gorska MM, Stafford SJ, Cen O, Sur S, Alam R (2004) Unc119, a novel activator of Lck/Fyn, is essential for T cell activation. J Exp Med 199:369-379.
16. Gudz TI, Komuro H, Macklin WB (2006) Glutamate stimulates oligodendrocyte progenitor migration mediated via an alphav integrin/myelin proteolipid protein complex. J Neurosci 26:2458-2466.
17. Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA, Connelly PA (1996) Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynTdependent T cell activation. J Biol Chem 271:695-701.
18. Head BP, Patel HH, Tsutsumi YM, Hu Y, Mejia T, Mora RC, Insel PA, Roth DM, Drummond JC, Patel PM (2008) Caveolin-1 expression is essential for N-methyl-D-aspartate receptor-mediated Src and extracellular signalregulated kinase 1/2 activation and protection of primary neurons from ischemic cell death. FASEB J 22:828-840.
19. Hou XY, Zhang GY, Yan JZ, Liu Y (2003) Increased tyrosine phosphorylation of alpha(1C) subunits of L-type voltage-gated calcium channels and interactions among Src/Fyn, PSD-95 and alpha(1C) in rat hippocampus after transient brain ischemia. Brain Res 979:43-50.
20. Hoyte LC, Papadakis M, Barber PA, Buchan AM (2006) Improved regional cerebral blood flow is important for the protection seen in a mouse model of late phase ischemic preconditioning. Brain Res 1121:231-237.
21. Hu H, Yamashita S, Hua Y, Keep RF, Liu W, Xi G (2010) Thrombininduced neuronal protection: role of the mitogen activated protein kinase/ ribosomal protein S6 kinase pathway. Brain Res 1361:93-101.
22. Inagaki K, Begley R, Ikeno F, Mochly-Rosen D (2005) Cardioprotection by epsilon-protein kinase C activation from ischemia: continuous delivery and antiarrhythmic effect of an epsilon-protein kinase C-activating peptide. Circulation 111:44-50.
23. Isosaka T, Hattori K, Kida S, Kohno T, Nakazawa T, Yamamoto T, Yagi T, Yuasa S (2008) Activation of Fyn tyrosine kinase in the mouse dorsal hippocampus is essential for contextual fear conditioning. Eur J Neurosci 28:973-981.
24. Jia J, Wang X, Li H, Han S, Zu P, Li J (2007) Activations of nPKCepsilon and ERK1/2 were involved in oxygen-glucose deprivation-induced neuroprotection via NMDA receptors in hippocampal slices of mice. J Neurosurg Anesthesiol 19:18-24.
25. Jiang X, Mu D, Biran V, Faustino J, Chang S, Rincón CM, Sheldon RA, Ferriero DM (2008) Activated Src kinases interact with theN-methyl-Daspartate receptor after neonatal brain ischemia. Ann Neurol 63:632-641.
26. Keep RF, Wang MM, Xiang J, Hua Y, Xi G (2010) Is there a place for cerebral preconditioning in the clinic? Transl Stroke Res 1:4-18.
27. Kennedy J, Buchan AM (2005) C-EPO: ready for prime-time preconditioning? [Review]. Cerebrovasc Dis 19:272-273.
28. Kim MJ, Park MT, Yoon CH, Byun JY, Lee SJ (2008) Activation of Lck is critically required for sphingosine-induced conformational activation of Bak and mitochondrial cell death. Biochem Biophys Res Commun 370:353-358.
29. Lin CH, Chen PS, Gean PW (2008) Glutamate preconditioning prevents neuronal death induced by combined oxygen-glucose deprivation in cultured cortical neurons. Eur J Pharmacol 589:85-93.
30. Lo EH, Dalkara T, Moskowitz MA (2003) Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4:399-415.
31. Malhotra S, Savitz SI, Ocava L, Rosenbaum DM (2006) Ischemic preconditioning is mediated by erythropoietin through PI-3 kinase signaling in an animal model of transient ischemic attack. J Neurosci Res 83:19-27.
32. Manzerra P, Behrens MM, Canzoniero LM, Wang XQ, Heidinger V, Ichinose T, Yu SP, Choi DW (2001) Zinc induces a Src family kinase-mediated up-regulation of NMDA receptor activity and excitotoxicity. Proc Natl Acad Sci USA 98:11055-11061.
33. McLaughlin B, Hartnett KA, Erhardt JA, Legos JJ, White RF, Barone FC, Aizenman E (2003) Caspase 3 activation is essential for neuroprotection in preconditioning. Proc Natl Acad Sci USA 100:715-720.
34. Meyn MA 3rd, Smithgall TE (2008) Small molecule inhibitors of Lck: the search for specificity within a kinase family. Mini Rev Med Chem 8:628-637.
35. Moncayo J, de Freitas GR, Bogousslavsky J, Altieri M, van Melle G (2000) Do transient ischemic attacks have a neuroprotective effect? Neurology 54:2089-2094.
36. Obrenovitch TP (2008) Molecular physiology of preconditioning-induced brain tolerance to ischemia. Physiol Rev 88:211-247.
37. Omri B, Crisanti P, Marty MC, Alliot F, Fagard R, Molina T, Pessac B (1996) The Lck tyrosine kinase is expressed in brain neurons. J Neurochem 67:1360-1364.
38. Palacios EH, Weiss A (2004) Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. Oncogene 23:7990-8000.
39. Ping P, Zhang J, Zheng YT, Li RC, Dawn B, Tang XL, Takano H, Balafanova Z, Bolli R (1999) Demonstration of selective protein kinase C-dependent activation of Src and Lck tyrosine kinases during ischemic preconditioning in conscious rabbits. Circ Res 85:542-550.
40. Ping P, Song C, Zhang J, Guo Y, Cao X, Li RC, Wu W, Vondriska TM, Pass JM, Tang XL, Pierce WM, Bolli R (2002) Formation of protein kinase C (epsilon)-Lck signaling modules confers cardioprotection. J Clin Invest 109:499-507.
41. Plesnila N, Zinkel S, Le DA, Amin-Hanjani S, Wu Y, Qiu J, Chiarugi A, Thomas SS, Kohane DS, Korsmeyer SJ, Moskowitz MA (2001) BID mediates neuronal cell death after oxygen/ glucose deprivation and focal cerebral ischemia. Proc Natl Acad Sci USA 98:15318-15323.
42. Rajanikant GK, Zemke D, Senut MC, Frenkel MB, Chen AF, Gupta R, Majid A (2007) Carnosine is neuroprotective against permanent focal cerebral ischemia in mice. Stroke 38:3023-3031.
43. Raval AP, Dave KR, Mochly-Rosen D, Sick TJ, Pérez-Pinzón MA (2003) Epsilon PKC is required for the induction of tolerance by ischemic and NMDA-mediated preconditioning in the organotypic hippocampal slice. J Neurosci 23:384-391.
44. Ruscher K, Shamloo M, Rickhag M, Ladunga I, Soriano L, Gisselsson L, Toresson H, Ruslim-Litrus L, Oksenberg D, Urfer R, Johansson BB, Nikolich K, Wieloch T (2011) The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke. Brain 134:732-746.
45. Salmond RJ, Filby A, Qureshi I, Caserta S, Zamoyska R (2009) T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance. Immunol Rev 228:9-22.
46. Salter MW, Kalia LV (2004) Src kinases: a hub for NMDA receptor regulation. Nat Rev Neurosci 5:317-328.
47. Samraj AK, Stroh C, Fischer U, Schulze-Osthoff K (2006) The tyrosine kinase Lck is a positive regulator of the mitochondrial apoptosis pathway by controlling Bak expression. Oncogene 25:186-197.
48. Schlessinger J (2000) New roles for Src kinases in control of cell survival and angiogenesis. Cell 100:293-296.
49. Slevin M, Kumar P, Gaffney J, Kumar S, Krupinski J (2006) Can angiogenesis be exploited to improve stroke outcome? Mechanisms and therapeutic potential. Clin Sci 111:171-183.
50. Stenzel-Poore MP, Stevens SL, Simon RP (2004) Genomics of preconditioning. Stroke 35:2683-2686.
51. Suzuki T, Okumura-Noji K (1995) NMDA receptor subunits epsilon 1 (NR2A) and epsilon 2 (NR2B) are substrates for Fyn in the postsynaptic density fraction isolated from the rat brain. Biochem Biophys Res Commun 216:582-588.
52. Takagi N, Cheung HH, Bissoon N, Teves L, Wallace MC, Gurd JW (1999) The effect of transient global ischemia on the interaction of Src and Fyn with the N-methyl-D-aspartate receptor and postsynaptic densities: possible involvement of Src homology 2 domains. J Cereb Blood Flow Metab 19:880-888.
53. Takasu MA, Dalva MB, Zigmond RE, Greenberg ME (2002) Modulation of NMDA receptor-dependent calcium influx and gene expression through EphB receptors. Science 295:491-495.
54. Tauskela JS, Brunette E, Monette R, Comas T, Morley P (2003) Preconditioning of cortical neurons by oxygen-glucose deprivation: tolerance induction through abbreviated neurotoxic signaling. Am J Physiol Cell Physiol 285:C899-C911.
55. Ueda H, Fujita R, Yoshida A, Matsunaga H, Ueda M (2007) Identification of prothymosin-alpha1, the necrosis-apoptosis switch molecule in cortical neuronal cultures. J Cell Biol 176:853-862.
56. Waegell W, Babineau M, Hart M, Dixon K, McRae B, Wallace C, Leach M, Ratnofsky S, Belanger A, Hirst G, Rossini A, Appel M, Mordes J, Greiner D, Banerjee S (2002) A420983, a novel, small molecule inhibitor of LCK prevents allograft rejection. Transplant Proc 34:1411-1417.
57. Watanabe R, Ishiura N, Nakashima H, Kuwano Y, Okochi H, Tamaki K, Sato S, Tedder TF, Fujimoto M (2010) Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J Immunol 184:4801-4809.
58. Wetzel M, Li L, Harms KM, Roitbak T, Ventura PB, Rosenberg GA, Khokha R, Cunningham LA (2008) Tissue inhibitor of metalloproteinases-3 facilitates Fas-mediated neuronal cell death following mild ischemia. Cell Death Differ 15:143-151.
59. Wu HY, Hsu FC, Gleichman AJ, Baconguis I, Coulter DA, Lynch DR (2007) Fyn-mediated phosphorylation of NR2B Tyr-1336 controls calpainmediated NR2B cleavage in neurons and heterologous systems. J Biol Chem 282:20075-20087.
60. Yim YI, Sun T, Wu LG, Raimondi A, De Camilli P, Eisenberg E, Greene LE (2010) Endocytosis and clathrin-uncoating defects at synapses of auxilin knockout mice. Proc Natl Acad Sci USA 107:4412-4417.
61. Zemke D, Smith JL, Reeves MJ, Majid A (2004) Ischemia and ischemic tolerance in the brain: an overview. Neurotoxicology 25:895-904.